Skip to main content

Verrica Pharmaceuticals Inc.

VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660334

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

Superinvestors holding VRCA, Q2 2026

See all superinvestors

No superinvestor reported holding VRCA in Q2 2026.